Revisiting Multi-Omics Data to Unravel Galectins as Prognostic Factors in Head and Neck Squamous Cell Carcinoma

• Published in: Biomedicines Vol. 12; no. 3; p. 529
• Main Authors: Barros, Oriana, D’Agostino, Vito Giuseppe, Santos, Lucio, Ferreira, Rita, Vitorino, Rui
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.02.2024; MDPI
• Subjects: B cells; Biomarkers; Cancer therapies; Cells; Chemotherapy; Comparative analysis; Datasets; Development and progression; galectins; Gene expression; Genomics; Head & neck cancer; Head and neck carcinoma; head and neck squamous cell carcinoma; Human papillomavirus; Internet software; Medical prognosis; Metastasis; multi-omics; Papillomavirus infections; Prognosis; RNA; RNA sequencing; Squamous cell carcinoma; Survival analysis; Tumor microenvironment; Tumor proteins; Tumors; Portugal; multi-omics; galectins; prognosis; head and neck squamous cell carcinoma
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12030529

Head and Neck Squamous Cell Carcinoma (HNSCC) is a malignant cancer with a poor prognosis. Galectins (Gal) have been the subject of intensive research, but the comparative prognostic value of each Gal type is not yet understood. Therefore, a literature search for evaluating galectins as prognostic biomarkers in HNSCC was conducted. The relationship between Gal expression in HNSCC with HPV and TP53 mutational status was assessed using the UALCAN database. The impact of these biomarkers on prognosis was analyzed using ToPP and CPPA web tools. The expression of galectins in the tumor microenvironment and the impact on prognosis depending on the cancer immune subtype were analyzed using single-cell RNA sequencing. Gal-1 and Gal-3BP were shown to be promising biomarkers with a triple function for the prediction of HPV and TP53 mutational status, stratification of the HNSCC prognosis, and prediction of the response to treatment. In addition, these two galectins have been shown to be most influenced by the tumor microenvironment of HNSCC. Gal-1 and Gal-3BP are the most promising galectins in HNSCC. Furthermore, this study highlights the need for further studies to evaluate galectins in HNSCC and clarify the role of individual Gals in the patient’s stratification.